Application of crystallization technologies to process development and manufacture of active pharmaceutical ingredients

被引：0
|
作者：
Rose, PR [1 ]
机构：
[1] Pfizer Inc, Chem Res & Dev, Groton, CT 06340 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
530-ORGN
引用
收藏
页码：U3344 / U3345
页数：2
相关论文
共 50 条
  • [31] Synthetic Development of Key Intermediates and Active Pharmaceutical Ingredients (APIs)
    Laha, Joydev K.
    Zhou, Jianrong Steve
    SYNTHESIS-STUTTGART, 2024, 56 (04): : III - IV
  • [32] Asymmetric organocatalysis in drug discovery and development for active pharmaceutical ingredients
    Burke, Anthony J.
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (01) : 37 - 46
  • [33] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37
  • [34] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2013, 981 : 29 - 29
  • [35] Challenges in the development of hydrate phases as active pharmaceutical ingredients - An example
    Feth, Martin P.
    Nagel, Norbert
    Baumgartner, Bruno
    Broeckelmann, Martin
    Rigal, David
    Otto, Bernhard
    Spitzenberg, Michael
    Schulz, Markus
    Becker, Bernd
    Fischer, Franceska
    Petzoldt, Christine
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 42 (1-2) : 116 - 129
  • [36] Example of finishing technologies as key elements for successful active pharmaceutical ingredient process development
    Müller, M
    Schneeberger, R
    Wieckhusen, D
    Cooper, M
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2004, 8 (03) : 376 - 380
  • [37] Computational Insights into Kinetic Hindrance Affecting Crystallization of Stable Forms of Active Pharmaceutical Ingredients
    Abramov, Yuriy A.
    Zhang, Peiyu
    Zeng, Qiao
    Yang, Mingjun
    Liu, Yang
    Sekharan, Sivakumar
    CRYSTAL GROWTH & DESIGN, 2020, 20 (03) : 1512 - 1525
  • [38] Technoeconomic Optimization of Continuous Crystallization for Three Active Pharmaceutical Ingredients: Cyclosporine, Paracetamol, and Aliskiren
    Diab, Samir
    Gerogiorgis, Dimitrios, I
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2018, 57 (29) : 9489 - 9499
  • [39] Application of Ultrasound Measurements as PAT Tools for Industrial Crystallization Process Development of Pharmaceutical Compounds
    Helmdach, Lydia
    Feth, Martin P.
    Ulrich, Joachim
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (01) : 110 - 121
  • [40] Development of active pharmaceutical ingredients for clinical development: Synthesis of a gamma secretase modulator
    Caron, Stephane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
12345